SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bob Trocchi who wrote (6201)2/16/1999 3:21:00 PM
From: Hank  Read Replies (1) | Respond to of 7041
 
The 163K royalty revenue for all of 1998 was the same as reported in their 3Q report. Therefore, no additional sales of Vasoscam occurred in the 4Q.'



To: Bob Trocchi who wrote (6201)2/16/1999 7:42:00 PM
From: Linda Kaplan  Read Replies (1) | Respond to of 7041
 
Bob: Your projection was a bit off, because the first quarter sales were $167,000 and the second quarter sales income was $0 and the third quarter sales income was minus $4,000. So the fourth quarter sales income could be minus $100,000 (as more stores return the materials from their stuffed channels). Thus the annual income would not be $1 million but rather more like $60,000.

Linda


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News